Biotech Deals 2024. Why 2024 could be even hotter for m&a. Biotech rally gets $100 billion m&a lift with more deals to come.
The biotech sector saw a surge of m&a activity at the end. Few signs of cooling in sector m&a after 46 deals during 2023.
Big pharma has plenty of.
The company expects 2024 revenue of $15.33 billion to $15.58 billion, versus its previous forecast of between $15.4 billion and $15.65 billion, as a strengthening.
Why 2024 could be even hotter for m&a.
Prometheus created a lot of buzz with midstage data for bowel disease candidate pra023 late last year.
